中国视角下的新冠肺炎最新诊断方法演进
M LIU, J LYU, X ZHENG, Z LIANG, B LEI… - Journal of Zhejiang …, 2023 - jzus.zju.edu.cn
… and treat COVID-19 patients. This review describes the variety of such methods used in
China, providing an important reference in the field of the clinical diagnosis of COVID-19. …
China, providing an important reference in the field of the clinical diagnosis of COVID-19. …
[PDF][PDF] 恢复期血浆在新型冠状病毒肺炎成人患者治疗中的应用
李双玲， 赵鸿， 孙月明， 王鹏， 李海霞… - 中华危重病急救 …, 2020 - cccm-em120.com
… of CP in the treatment of COVID-19 patients, the safety of … choose CP for the treatment of
adult patients with COVID-19. … the level of neutralizing antibody against pandemic influenza …
adult patients with COVID-19. … the level of neutralizing antibody against pandemic influenza …
噬菌体抗体展示技术及其在抗新冠病毒抗体发现中的应用
王加利， 和似琦， 康子茜， 王建勋 - 生物技术通报, 2022 - biotech.aiijournal.com
… for generating antigen specific antibodies in a matter of weeks… disease(COVID-19),the
research for neutralizing antibodies is … antibody libraries,many different SARS-CoV-2 neutralizing …
research for neutralizing antibodies is … antibody libraries,many different SARS-CoV-2 neutralizing …
跨血脑屏障的非侵入性基因传递: 现在和将来的观点
S Kimura, H Harashima - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… the production of neutralizing antibodies to the vectors and … applied to mRNA vaccinations
for COVID-19, and the diversity … particularly promising for treating CNS disorders including …
for COVID-19, and the diversity … particularly promising for treating CNS disorders including …
[HTML][HTML] JAMA: COVID-19 免疫之途径及疫苗
DS Stephens, MJ McElrath - wenxuecity.com
… Covid-19爆发已超过8个月,而在全球范围内发生了数百万次感染之后,出现了许多零散的病例
报告,这些报告大多是在最初的轻度COVID-19… 细胞毒性T细胞在COVID-19急性呼吸窘迫综合征…
报告,这些报告大多是在最初的轻度COVID-19… 细胞毒性T细胞在COVID-19急性呼吸窘迫综合征…
[HTML][HTML] 新型冠状病毒疫苗研究策略分析
杨利敏， 田德雨， 刘文军 - 生物工程学报, 2020 - cjb.ijournals.cn
… The vaccine against COVID-19, regarded as an effective prophylactic strategy for control …
of COVID-19 vaccine. The present paper hopes to provide some insights for COVID-19 …
of COVID-19 vaccine. The present paper hopes to provide some insights for COVID-19 …
[PDF][PDF] 血管紧张素转换酶2 在新型冠状病毒肺炎(COVID-19) 发病机制及治疗中的作用研究进展
杨吕， 何庆 - 中国药理学与毒理学杂志, 2020 - cjpt.magtechjournal.com
… A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its
… COVID-19, is of great significance in the clinical treatment of and drug development against …
… COVID-19, is of great significance in the clinical treatment of and drug development against …
[HTML][HTML] 复检核酸阳性的新型冠状病毒感染者分布及传染性特征分析
李志丽， 李昱， 陈秋兰， 杨孝坤， 赵宏婷， 姜欣丽… - 中华流行病学 …, 2021 - html.rhhz.net
… the improvement of case management and the development of … , the total antibody and
neutralizing antibody positive rates were … Protocol of diagnosis and treatment for COVID-19(trial …
neutralizing antibody positive rates were … Protocol of diagnosis and treatment for COVID-19(trial …
新型冠状病毒IgM-IgG 抗体检测试剂盒的制备及对15 例患者临床应用初试
李焕杰， 欧兰香， 陈虹， 陈健， 耿军… - 山东大学学报 …, 2020 - yxbwk.njournal.sdu.edu.cn
… from 15 PCR confirmed COVID-19 patients were detected and … progress of SARS-CoV-2
antibody IgM-IgG on virus. Results … antibody may be helpful for the diagnosis and treatment on …
antibody IgM-IgG on virus. Results … antibody may be helpful for the diagnosis and treatment on …
[HTML][HTML] 靶向人白介素-6蛋白的治疗性单克隆抗体研究进展*
李开通， 刘金青， 蔡望伟， 肖曼， 沈倍奋… - 中国生物工程 …, 2022 - manu60.magtech.com.cn
… In addition, the abnormal expression of IL-6 also plays an important role in COVID-19’s
cytokine storm syndrome (CSS). In general, treatments that block key molecules in the IL-6 …
cytokine storm syndrome (CSS). In general, treatments that block key molecules in the IL-6 …